Advanced body composition imaging to improve outcomes in lung transplantation

Active Grant Awarded Last action

Award ID
R01HL180880
Recipient
Awarding agency
Obligated
$1,537,686

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date 27% complete
Place of performance
Philadelphia, PA 19104, USA

Award details come from USAspending.gov.

Description

Abstract
Median survival after lung transplantation (TX) is only 6.7 years, compared to >11 years after other solid organ TX. Obesity increases risk of death on the TX waitlist, early severe lung injury (primary graft dysfunction, PGD), and death after lung TX. We have repeatedly shown that measures of adipose distribution on computed tomography (CT) scan identify candidates at risk for pre-TX, peri-operative, and post-TX morbidity and mortality beyond body mass index (BMI). Measures of adipose distribution are routinely used to quantify risk in the general population. In fact after screening with BMI, obesity guidelines recommend further risk stratification by adipose distribution. How to similarly integrate adipose distribution measures into lung TX risk assessments is a knowledge GAP. Better quantification of obesity-related risk is critical to ensuring that candidates at risk for these outcomes are (I) waitlisted before they are too sick to undergo TX, and (II) receive operative management that minimizes the risk of post-TX morbidity and mortality. Optimal waitlist timing balances pre-TX and post-TX survival: sick enough to benefit from TX but not so sick that the patient develops complications and dies soon after TX. Guidelines recommend waitlisting candidates at >50% risk of death within 2 years without TX and >80% likelihood of living 5-years post-TX. CT-measured adipose distribution is associated with survival in both periods: risk of death without TX (aim 1) and risk of death after TX (aim 3) beyond BMI. Inclusion of adipose distribution measures in these risk assessments will improve timely waitlisting leading to decreased waitlist mortality and increased post-TX survival. Measures of adipose distribution will also inform operative management. Once a candidate is added to the waitlist, estimates of PGD risk are critical to selecting the operative approach that minimizes post-TX morbidity and mortality (e.g. extracorporeal support, bilateral VS single lung TX). We have shown that CT-measured adipose distribution identifies recipients at risk for severe PGD beyond BMI (aim 2). IT is now feasible to obtain these CT measures in clinical practice: we validated an automated tool in radiology software already in use at our center. The logical next step is to establish metrics of adipose distribution that inform TX risk assessments. The lung transplant outcomes group multi-center cohort study (ltog, U01 HL145435) prospectively enrolled lung TX candidates to identify risk factors for PGD and death. Since chest CT scans are universally performed in lung TX to evaluate the lungs, we will retrospectively collect these clinical CTS to measure adipose distribution. We will leverage ltog's data on TX recipients while expanding the database to include all subjects evaluated for TX. We will establish metrics of adipose distribution that predict 2-year survival without TX (aim 1), identify recipients at high risk of PGD (aim 2), and improve discrimination of post-TX survival (aim 3). We will externally validate our findings in a cohort at washu previously used to validate our ltog PGD risk score. Accomplishing these aims will improve lung TX outcomes by optimizing waitlist timing and informing operative management.

Transactions

Action Obligated Date
Amendment $704,298
Amendment $0
Original award $833,388

Subawards

Subrecipient Amount Awarded
Upmc "The purpose of this subcontract is to serve as a collaborating site for an ancillary study to the Lung Transplant Outcomes Group (LTOG). The goals of the… $36,600
The Leland Stanford Junior University "The purpose of this subcontract is to serve as a collaborating site for an ancillary study to the Lung Transplant Outcomes Group (LTOG). The goals of the… $45,411
The Johns Hopkins University "Site Subcontract on R01 application "" "" The purpose of this subcontract is to serve as a collaborating site for Dr. Michaela Anderson's R01 application… $35,217
Duke University "The purpose of this subcontract is for Dr. Laurie Snyder to serve as a collaborator for a study of computed-tomography based metrics of body composition that… $48,592
The Trustees Of Columbia University In The City Of New York "Site Subcontract on ancillary R01 application ""Advanced body composition imaging to improve outcomes in lung transplantation"" The purpose of this subcontract… $41,697
The Regents Of The University Of California. San Francisco "Site Subcontract on R01 application "" "" The purpose of this subcontract is to serve as a collaborating site for Dr. Michaela Anderson's R01 application… $54,549

Quick answers

Who received award R01HL180880?

R01HL180880 was awarded to The Trustees Of The University Of Pennsylvania by National Heart Lung and Blood Institute (National Institutes of Health) on August 21, 2025.

How much is award R01HL180880 worth?

$1,537,686 has been obligated on R01HL180880.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award